Nicholas Stieg is a business development professional focused on bio and health technology, with experience in preclinical collaborations, clinical partnerships, and strategic transactions. Currently, they hold roles in investor relations and corporate development at Celularity Inc. and co-founded Universal Quantum Computer, where they develop quantum computing applications in pharmacology. Previously, Nicholas co-founded New Direction Biosciences and worked in various business development and investment banking roles, showcasing a diverse background in healthcare innovation and financial analysis. They earned a Bachelor's degree in Economics and History from Cornell University and studied International Economics at Oxford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices